Use of combination of satins as antagonists of SPARC in stomach cancer: an in silico study

Use of combination of satins as antagonists of SPARC in stomach cancer: an in silico study

This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2019.

Bibliografiset tiedot
Päätekijä:	Rashed, Sadman Sakib Bin
Muut tekijät:	Kabir, Eva Rahman
Aineistotyyppi:	Project report
Kieli:	English
Julkaistu:	Brac University 2019
Aiheet:	SPARC Statins Stomach / Gastric cancer Drug repurposing Molecular docking Protein-ligand interactions Stomach > Cancer.
Linkit:	http://hdl.handle.net/10361/12387

Samankaltaisia teoksia

Role of statins as antagonists of SPARC in gastric cancer
Tekijä: Shahmat, Rad
Julkaistu: (2019)

Target specificity of different phytochemicals in preventing the binding of OxLDL To LOX-1: An in silico approach
Tekijä: Alam, Ratul, et al.
Julkaistu: (2023)

Molecular docking of Fluvastatin and Teneligliptin targeting AT1R in hypertension
Tekijä: Jahan, Esrat
Julkaistu: (2020)

Inhibition of Fibroblast Activation Protein alpha (FAP-α) in Colorectal Cancer
Tekijä: Tabassum, Azwada
Julkaistu: (2021)

Understanding Helicobacter pylori Infection Prevalence and Associated Factors in slum and swampy areas of Narayanganj, Bangladesh: Findings from Medical Camps
Tekijä: Jarin, Ismath, et al.
Julkaistu: (2024)

Role of toll-like receptors in cancer immunotherapy– a review
Tekijä: Khan, Rezia Nowrin
Julkaistu: (2021)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
Tekijä: Araf, Faiaz Fahim
Julkaistu: (2024)

A comprehensive review on drug repurposing in cancer treatment
Tekijä: Sarkar, Onusree
Julkaistu: (2024)

A comprehensive bioinformatics analysis of BRAF in cancer
Tekijä: Ahmed, Bagdad
Julkaistu: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Tekijä: Chakraborty, Anuradha
Julkaistu: (2024)

Molecules associated with the development of lung cancer
Tekijä: Rahman, Adree, et al.
Julkaistu: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
Tekijä: Das, Reshita
Julkaistu: (2024)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
Tekijä: Pecorino, Lauren
Julkaistu: (2012)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Tekijä: Flora, Sanzida Alam
Julkaistu: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
Tekijä: Oishy, Jannatun Noor
Julkaistu: (2024)

Heat shock protein: potential approach for chemotherapy
Tekijä: Sykut, Md. Rezaul Hoque
Julkaistu: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
Tekijä: Abir, Shifaty Nur
Julkaistu: (2024)

Statistics and informatics in molecular cancer research

A computational approach to find alternative drugs for managing depression
Tekijä: Mubashira, Musharrat Shaheed
Julkaistu: (2022)

A review on principles of molecular docking and its application in drug discovery
Tekijä: Sharif Ezzaz, Ahamed
Julkaistu: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Tekijä: Hasan, Amit
Julkaistu: (2024)

Cancer risk factors: a critical review
Tekijä: Tabassum, Tahsina
Julkaistu: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
Tekijä: Nawar, Anika
Julkaistu: (2019)

A comprehensive in silico investigation into the pathogenic SNPs in RTEL1 gene and their biological consequences
Tekijä: Tanshee, Rifah Rownak
Julkaistu: (2023)

Anti-inflammatory effect of Statins in reducing the exacerbation and mortality rates of COPD patients: a review study
Tekijä: Shomi, Iffat Ara
Julkaistu: (2019)

Targeting BRAFV600E in the treatment of CRC
Tekijä: Roja, Mashwiyat Samrin
Julkaistu: (2024)

Trend in approval of targeted biologics in the last two decades
Tekijä: Siddika, Khadiza
Julkaistu: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Tekijä: Pial, Sazia Afrin
Julkaistu: (2018)

A review on potential anticancer properties of antidiabetic drugs: metformin and sulfonylureas
Tekijä: Hossain, Tamara
Julkaistu: (2024)

Epigenetic therapy in cancer
Tekijä: Abid, Md. Shadman Ridwan
Julkaistu: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
Tekijä: Khondokar, Faiza
Julkaistu: (2022)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
Tekijä: Zangmo, Thinley
Julkaistu: (2024)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
Tekijä: Rahman, Sanjida
Julkaistu: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
Tekijä: Jahan, Nusrat
Julkaistu: (2024)

Biosimilar in lymphoma treatment
Tekijä: Tanisha, Mehrin Haque
Julkaistu: (2021)

Current perspectives on cancer prevention strategies: implications for Bangladesh
Tekijä: Afrin, Sajia
Julkaistu: (2017)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
Tekijä: Hossain, Safa Binte
Julkaistu: (2019)

Potential of nanoparticles as a topical drug delivery system for skin cancer: a review
Tekijä: Islam, Karima
Julkaistu: (2022)

ক্যান্সার : মৃত্যু অবধারিত নয় /
Tekijä: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Point-of care diagnostic devices in cancer detection
Tekijä: Yasmin, Rizwana
Julkaistu: (2022)